Search clinical trials for: CF101 3mg

Total 12153 results

Amgen

Completed

A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis

Chronic Kidney Disease, Secondary Hyperparathyroidism

Belgium, United States, Germany, Poland, United Kingdom, Lithuania
Bayer

Completed

Japanese BAY1000394 Monotherapy Phase I Study

Neoplasms

Japan
Amgen

Completed

Safety Study of AMG 557 in Subjects With Lupus Arthritis

Lupus Arthritis, Systemic Lupus Erythematosus

United States, Taiwan, Germany, Denmark, Australia, United Kingdom, Malaysia, France
C. R. Bard

Terminated

Assessment of the Precision of the Sherlock 3CG Tip Positioning System (STAT-PICC)

No Specific Conditions Under Study. Primary Focus: Adult Subjects Who Require PICC Placement

United States
M.D. Anderson Cancer Center
Amgen

Withdrawn

AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC)

Prostate Cancer

United States
Amgen

Terminated

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With Psoriasis

Psoriasis

United States
Amgen

Completed

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis

Psoriasis

New Zealand, Australia
Ferring Pharmaceuticals
Ferring SAU

Completed

Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HP

Sterility

Spain
Amgen

Completed

Treatment for Patients With Osteoarthritis (OA)

Osteoarthritis
Timothy Roberts
Simons Foundation; Clinical Research Associates, LLC

Completed

MEG Study of Acute STX209 Effects in ASD

Autism Disorder

United States
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase II Study of HS-10353 in Participants With Postpartum Depression

Postpartum Depression
Beijing Anzhen Hospital

Not yet recruiting

Henagliflozin in Patients With Atrial Fibrillation (HENA-AF)

Atrial Fibrillation

China
Assistance Publique - Hôpitaux de Paris

Recruiting

Dyspnea Facial Recognition During Weaning (DYS-FEREA)

Dyspnea Invasive Mechanical Ventilation-associated

France
Shirley Ryan AbilityLab
National Institute of Neurological Disorders and Stroke (NINDS)

Recruiting

Vibration for Muscle Spasms After Spinal Cord Injury

Spinal Cord Injuries

United States
University of Southern California

Withdrawn

Surface EMG Biofeedback for Children With Cerebral Palsy

Cerebral Palsy | Movement Disorders | Dystonia | Spasticity | Hypertonia

United States
Amgen

Terminated

Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease

Chronic Graft Versus Host Disease cGVHD

United States, Japan, France, Belgium
Amgen

Completed

Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)

Thrombocytopenic Purpura
Powell Mansfield Inc.

Completed

Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx

Healthy | Amyotrophic Lateral Sclerosis | Obstructive Sleep Apnea | Muscular Dystrophies

United States
Boehringer Ingelheim

Completed

Phase I Dose Escalation of i.v. BI 836909 Monotherapy in Last Line Multiple Myeloma Patients

Multiple Myeloma

Germany, France
Cytokinetics

Withdrawn

Pharmacokinetic Study of Omecamtiv Mecarbil in Heart Failure Patients

Heart Failure
IRCCS San Camillo, Venezia, Italy

Completed

Hand MOtor Rehabilitation Using a EMG-biofeedback: a Cross-sectional Study (MORE)

Stroke | Hemiplegia | Stroke, Ischemic | Stroke Hemorrhagic | Hemiparesis

Italy
Istanbul Medipol University Hospital

Unknown

Electrophysiological Changes Based on the Palmaris Longus

Carpal Tunnel Syndrome | Palmaris Longus Muscle, Absence of | EMG Syndrome

Turkey
Amgen

Completed

Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

United States, Belgium, Canada, Denmark, Italy, Hungary, Germany, Switzerland, Netherlands, Australia, Russian Federation, Austria, France, United Kingdom, Czechia, Greece, Poland, Estonia, Latvia, Norway
Amgen

Completed

Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's Disease

Crohn's Disease

United States, Canada, Denmark, Belgium, Hungary, Switzerland, Netherlands, Austria, Czechia, France, United Kingdom, Germany
Reza Dana, MD

Completed

Treatment of Corneal Neovascularization With Topical Pazopanib

Corneal Neovascularization

United States
Amgen

Completed

Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes | Thrombocytopenia | MDS | Hematology
Amgen

Completed

Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects

Idiopathic Thrombocytopenic Purpura | Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Astellas Pharma Inc

Terminated

A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)

Bladder Function

United States
Amgen

Completed

Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Thrombocytopenia | Idiopathic Thrombocytopenic Purpura
IBSA Institut Biochimique SA

Completed

Prospective, Randomized, Controlled, Clinical Study on Tolerability and Efficacy of hMG-IBSA

Infertility

Italy
Amgen

Completed

Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study

Cardiovascular Disease

United States, Australia, Netherlands, Canada, Denmark, Iceland, Japan
University of Michigan

Enrolling by invitation

Studying Electromyographic Activity in Patients With Upper Limb Amputations

Amputation, Traumatic
Amgen

Completed

Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim

Idiopathic Thrombocytopenic Purpura

Italy, United States, Germany, Czechia, United Kingdom, Australia, Spain, Poland, France
Columbia University
Wallace H. Coulter Foundation; U.S. National Science Foundation

Completed

MyHand: An Active Hand Orthosis for Stroke Patients

Stroke

United States
King's College London
King's College Hospital NHS Trust

Completed

Predicting Infant Extubation Using Diaphragm Surface Electromyography (EMG)

Infant, Newborn, Disease

United Kingdom
Alaa Fouli Gaber Ebrahim

Unknown

Controlled Ovarian Hyperstimulation (COH) With Sequential HPFSH & HMG Versus Rec-F.S.H Alone in ICSI Cycle

Ovarian Stimulation in ICSI

Egypt
MedImmune LLC
Amgen

Completed

A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

United States, Sweden, France, United Kingdom
GlaxoSmithKline

Completed

A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD114044)

Muscular Dystrophies

France, Denmark, Germany, Belgium, Spain, Turkey, Korea, Republic of, Brazil, Netherlands, Italy, Chile, Japan, Canada, Hungary, Russian Federation, Czechia, Poland, Norway, Argentina, Taiwan
University Hospital, Ghent
University Ghent

Completed

Uroflow Measurement With Electromyography (EMG) to Identify Lower Urinary Tract Symptoms (LUTS): Conducted on Healthy Children

Urologic Diseases | Lower Urinary Tract Symptoms

Belgium
University of Campinas, Brazil

Active, not recruiting

Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response (EDI-PIO)

Leukemia, Chronic Myeloid

Brazil
Amgen

Active, not recruiting

AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer

United States, Belgium, Austria, Singapore, Taiwan, Japan
Genor Biopharma Co., Ltd.

Unknown

Phase I Clinical Study of GB222 to Evaluate the Safety, Tolerability and PK Profiles.

Brain Tumor

China
Addpharma Inc.

Completed

Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072

Hypertension | Hyperlipidemias

Korea, Republic of
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Does Doxazosin Attenuate Stress-induced Smoking and Improve Clinical Outcomes?

Smoking

United States
China International Neuroscience Institution

Completed

Comparation Analgesia Efficiency With Propofol Combine Sevoflurane vs Propofol

Nociceptive Pain | Analgesic Adverse Reaction | Inhalant Use

China
Woman's
Novo Nordisk A/S

Recruiting

Treatment to Regress to Normoglycemia in Women With a Recent History of GDM (SWEET)

Pre Diabetes | Postpartum Disorder

United States
Hanlim Pharm. Co., Ltd.

Completed

A Dose-escalation Clinical Trial After Multiple Dosing of HL217 Eye Drop in Healthy Male Subjects

Healthy Subjects

France
Bausch Health Americas, Inc.

Terminated

AMG 827 in Subjects With Psoriatic Arthritis

Psoriatic Arthritis

United States, Canada
Medical University of Graz
Medical University of Vienna; Landesklinkum Wiener Neustadt; Klinik Ottakring; Medical... and other collaborators

Terminated

Ertugliflozin to Reduce Arrhythmic Burden in ICD/CRT patientS (ERASe-Trial) - a Phase III Study (ERASE)

Implantable Cardioverter-Defibrillators | Heart Failure With Reduced Ejection Fraction | Cardiac Resynchronization Therapy | Heart Failure With Mid Range Ejection Fraction

Austria
University of Valencia
Regedent AG, Zürich

Unknown

Comparison of Clinical and Radiographic Parameters in the Application of Cross-linked Hyaluronic Acid 1.8% and Enamel Matrix Derivative in Periodontal Regeneration.

Chronic Periodontitis | Periodontal Bone Loss

Search clinical trials for: CF101 3mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations